Lista de obras - Miguel Alcoceba - Dominio Público Uruguay

6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival

artículo científico publicado en 2020

<i>STAT3</i> and <i>STAT5B</i> Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features

scientific article published on 25 November 2020

A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients

artículo científico publicado en 2019

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

artículo científico publicado en 2016

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).

artículo científico publicado en 2009

Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma

artículo científico publicado en 2020

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

scientific article published on 06 January 2021

CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.

artículo científico publicado en 2014

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.

artículo científico publicado en 2018

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

scientific article published on 01 October 2008

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

artículo científico publicado en 2016

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.

artículo científico publicado en 2017

Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)

artículo científico publicado en 2020

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

artículo científico publicado en 2020

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

artículo científico publicado en 2013

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

artículo científico publicado en 2014

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

artículo científico publicado en 2013

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

artículo científico publicado en 2019

Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?

artículo científico

Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).

artículo científico publicado en 2011

From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation

artículo científico publicado en 2017

Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder

artículo científico publicado en 2019

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

artículo científico publicado en 2017

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

artículo científico publicado en 2013

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

artículo científico publicado en 2009

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

artículo científico publicado en 2015

Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.

artículo científico publicado en 2017

Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients

artículo científico publicado en 2020

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

scientific article published on 17 June 2019

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

artículo científico publicado en 2017

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

artículo científico publicado en 2012

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

artículo científico publicado en 2019

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.

artículo científico publicado en 2008

Low-count monoclonal B-cell lymphocytosis persists after 7 years of follow-up and is associated with a poorer outcome.

artículo científico publicado en 2018

Lymphoma Heterogeneity: Three Different Histological Pictures and One Unique Clone

artículo científico publicado en 2016

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

artículo científico publicado en 2013

Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2004

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

artículo científico publicado en 2016

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

scientific article published on 01 March 2009

Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance

artículo científico publicado en 2007

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

artículo científico publicado en 2012

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

artículo científico publicado en 2020

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

artículo científico publicado en 2009

Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.

artículo científico publicado en 2014

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

artículo científico publicado en 2018

Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series

artículo científico publicado en 2018

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

artículo científico publicado en 2016

Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation

artículo científico publicado en 2009

Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report

artículo científico publicado en 2017

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

artículo científico publicado en 2012

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma

artículo científico publicado en 2017

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

artículo científico publicado en 2017

Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

artículo científico publicado en 2019

Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia

scientific article published on 21 June 2018

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

artículo científico publicado en 2018

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

artículo científico publicado en 2017

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

scientific article published on 04 July 2018

Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

artículo científico publicado en 2014

Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats

scientific article published on 17 June 2011

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

artículo científico publicado en 2010

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.

artículo científico publicado en 2012

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma

scientific article published on 17 October 2006

The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.

artículo científico publicado en 2017

The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.

artículo científico publicado en 2016

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

artículo científico publicado en 2015

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

scientific article published on 07 April 2008

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

artículo científico publicado en 2008

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

artículo científico publicado en 2012

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.

artículo científico publicado en 2018

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

artículo científico publicado en 2010

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma

article

Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms

scientific article published on 01 May 2019

Lista de obras de Miguel Alcoceba

6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival

<i>STAT3</i> and <i>STAT5B</i> Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features

A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients

A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).

Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-Cell Lymphoma

Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative

CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.

Clinical and prognostic value of discrepancies in microsatellite DNA regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.

Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma

Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?

Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain).

From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation

Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder

HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis

HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma.

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.

Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.

Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.

Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.

Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.

Low-count monoclonal B-cell lymphocytosis persists after 7 years of follow-up and is associated with a poorer outcome.

Lymphoma Heterogeneity: Three Different Histological Pictures and One Unique Clone

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation

Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report

Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia.

Quantitative PCR: an alternative approach to detect common copy number alterations in multiple myeloma

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome

Reply to Brown et al: 'Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis'

Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemia

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukemia

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome

Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation

The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma

The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.

The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.

The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.

The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study.

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma

Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms